USE OF COMPREHENSIVE GERIATRIC ASSESSMENT IN ONCOLOGY: A LITERATURE REVIEW

N K Myrzaliyev, Sayakhat T. Olzhayev, Baurzhan J. Adjibayev, A. Abzhalelov, S. Joldassov

2025

Data confidence 70 medium

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Relevance: Over 60% of patients who are first diagnosed with cancer are aged 65 and older. This article analyzes the impact of Comprehensive Geriatric Assessment (CGA) on cancer treatment outcomes in elderly patients.The study aimed to analyze the relationship between (CGA), frailty syndrome (FS), and cancer treatment outcomes in elderly patients.Methods: An analysis of publications from the last 10 years related to the subject of this review was conducted without using language filters.Results: A relationship between frailty syndrome (FS) and survival, mortality, and other outcomes in oncogeriatric patients was established. An analysis of outcome assessment measures for patients with frailty syndrome was conducted. Combinations of CGA elements applicable for the evaluation of oncogeriatric patients were highlighted.Conclusion: CGA proves to be beneficial in oncogeriatric practice. It is essential to carefully select CGA elements to optimize clinical practice and solve research tasks. Further research in this field makes an important contribution to the development of oncogeriatric medicine and improving the effectiveness of cancer treatment in elderly patients.